Measles, Mumps and Rubella Vaccine: Current Safety Issues

By West R.  

BioDrugs, Vol. 12, Iss. 6, 1999-12 ,pp. : 423-429

Adis International

Access to resources Recommend Favorite

Reduced-Antigen, Combined Diphtheria, Tetanus, and Acellular Pertussis Vaccine (Boostrix™): A Review of its Use as a Single-Dose Booster Immunization

By Frampton James E.   Keating Gillian M.  

BioDrugs, Vol. 20, Iss. 6, 2006-01 ,pp. : 371-389

Adis International

Access to resources Recommend Favorite

Serum opsonic and bactericidal activity after Neisseria meningitidis group A+C and Haemophilus influenzae type b vaccination: a comparison of three functional assays

By Hugosson S.   Fredlund H.   Kayhty H.   Olcen P.  

Serodiagnosis and Immunotherapy in Infectious Disease, Vol. 8, Iss. 3, 1997-01 ,pp. : 213-220

Elsevier

Access to resources Recommend Favorite

Tdap 5 Vaccine (Covaxis®): A Review of its Use as a Single-Booster Immunization for the Prevention of Tetanus, Diphtheria, and Pertussis in Children (Aged ≥4 Years), Adolescents, and Adults

By Scott Lesley J.  

BioDrugs, Vol. 24, Iss. 6, 2010-12 ,pp. : 387-406

Adis International

Access to resources Recommend Favorite

Combined, Reduced-Antigen Content Tetanus, Diphtheria, and Acellular Pertussis Vaccine (Boostrix®)†: A Review of its Use as a Single-Dose Booster Immunization in Individuals Aged 10-64 Years in the US

By Plosker Greg L.  

BioDrugs, Vol. 23, Iss. 4, 2009-08 ,pp. : 253-267

Adis International

Access to resources Recommend Favorite